Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer - Reply

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF UROLOGY | 2001年 / 165卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1467 / 1467
页数：1
相关论文
共 50 条
  • [21] Serial urinary IL-2, IL-6, IL-8, TNFα, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCG
    Sanchez-Carbayo, M
    Urrutia, M
    Romani, R
    Herrero, M
    De Buitrago, JMG
    Navajo, JA
    ANTICANCER RESEARCH, 2001, 21 (4B) : 3041 - 3047
  • [22] Usefulness of urinary NMP22 to detect tumor recurrence of superficial bladder cancer after transurethral resection
    Naoto Miyanaga
    Hideyuki Akaza
    Sadamu Tsukamoto
    Toru Shimazui
    Mikinobu Ohtani
    Satoru Ishikawa
    Ryosuke Noguchi
    Fumio Manabe
    Yukiko Nishijima
    Koji Kikuchi
    Ken Sato
    Hitoshi Hayashi
    Fukuji Kondo
    Hiroshi Shiraiwa
    Osamu Aoyama
    International Journal of Clinical Oncology, 2003, 8 (6) : 369 - 373
  • [23] NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer
    Casella, R
    Lehmann, K
    Gasser, TC
    JOURNAL OF UROLOGY, 1999, 162 (02): : 500 - 501
  • [24] NMP22: A sensitive, cost-effective test in patients at risk for bladder cancer
    Zippe, C
    Pandrangi, L
    Potts, JM
    Kursh, E
    Novick, A
    Agarwal, A
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2621 - 2623
  • [25] NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer
    Zippe, C
    Pandrangi, L
    Agarwal, A
    JOURNAL OF UROLOGY, 1999, 161 (01): : 62 - 65
  • [26] Evaluation of Urine Tumor-Associated Trypsin Inhibitor, CYFRA 21-1, and Urinary Bladder Cancer Antigen for Detection of High-Grade Bladder Carcinoma
    Gkialas, Loannis
    Papadopoulos, Georgios
    Iordanidou, Lydia
    Stathouros, Georgios
    Tzavara, Chara
    Gregorakis, Alkiviadis
    Lykourinas, Michael
    UROLOGY, 2008, 72 (05) : 1159 - 1163
  • [27] Cytokeratins (UBC and CYFRA 21-1) and molecular protein matrix as urinary tumor markers in the diagnosis of bladder cancer
    Sánchez-Carbayo, M
    Urrutia, M
    Hernández-Cereceño, ML
    de Buitrago, JMG
    Navajo, JA
    MEDICINA CLINICA, 2000, 114 (10): : 361 - 366
  • [28] Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder
    Kibar, Y
    Goktas, S
    Kilic, S
    Yaman, H
    Onguru, O
    Peker, AF
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2006, 36 (01): : 31 - 38
  • [29] The Use of Urinary Nuclear Matrix Protein 22 (NMP22) as a Diagnostic Adjunct to Urine Cytology for Monitoring of Recurrent Bladder Cancer-Institutional Experience and Review
    Onal, Binnur
    Han, Unsal
    Yilmaz, Sinasi
    Koybasioglu, Fulya
    Altug, Ugur
    DIAGNOSTIC CYTOPATHOLOGY, 2015, 43 (04) : 307 - 314
  • [30] Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer
    Stieber, P
    Schmeller, N
    Schambeck, C
    Hofmann, K
    Reiter, W
    Hasholzner, U
    FatehMoghadam, A
    ANTICANCER RESEARCH, 1996, 16 (6B) : 3793 - 3798
12345